Agilent Technologies earnings release, August 26, 2026

Agilent Technologies, Inc. (A) · Form 8-K, Item 2.02 · Filed · SEC filing

Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results

Delivers strong Q3 results and raises FY26 revenue growth, margin expansion, and non-GAAP EPS

Financial statements

Income Statement

Three Months Ended — PRELIMINARY

Three Months Ended – July 31, – 2026Three Months Ended – July 31, – 2025Nine Months Ended – July 31, – 2026Nine Months Ended – July 31, – 2025
Net revenue1,8781,7385,5115,087
Costs and expenses:Cost of products and services8368502,5332,434
Costs and expenses:Research and development123111366336
Costs and expenses:Selling, general and administrative4754171,4161,281
Costs and expenses:Total costs and expenses1,4341,3784,3154,051
Costs and expenses:Income from operations4443601,1961,036
Costs and expenses:Interest income15164345
Costs and expenses:Interest expense-29-28-79-85
Costs and expenses:Other income (expense), net141856-3
Costs and expenses:Income before taxes4443661,216993
Costs and expenses:Provision for income taxes8230210124
Costs and expenses:Net income3623361,006869
Net income per share:Basic1.281.183.553.05
Net income per share:Diluted1.281.183.553.05
Weighted average shares used in computing net income per share:Basic282284283285
Weighted average shares used in computing net income per share:Diluted283285283285

Income Statement

The preliminary non-GAAP net income and diluted EPS reconciliation is estimated based on our current information. (In millions, except margin data)

AGILENT TECHNOLOGIES, INC. – RECONCILIATION OF NON-GAAP INCOME FROM OPERATIONS AND OPERATING MARGIN – (Unaudited) – PRELIMINARY – Year Over Year – Percent Pts – Inc/(Dec)
OtherNon-GAAP income from operations3.2%

Income Statement

Life Sciences and Diagnostics Markets Segment

Q3'26Q3'25
Revenue746670
Gross Margin, %55.550.5
Income from Operations176118
Operating margin, %23.517.6

Income Statement

Agilent CrossLab Segment

Q3'26Q3'25
Revenue786744
Gross Margin, %5755.1
Income from Operations270248
Operating margin, %34.333.3

Income Statement

Applied Markets Segment

Q3'26Q3'25
Revenue346324
Gross Margin, %57.353.6
Income from Operations8671
Operating margin, %24.921.8

Balance Sheet

PRELIMINARY

July 31, 2026October 31, 2025
Current assets:Cash and cash equivalents1,7581,789
Current assets:Accounts receivable, net1,4781,487
Current assets:Inventory1,1171,025
Current assets:Other current assets340293
Current assets:Total current assets4,6934,594
Current assets:Property, plant and equipment, net2,1342,023
Current assets:Goodwill5,0304,473
Current assets:Other intangible assets, net906445
Current assets:Long-term investments130133
Current assets:Other assets1,0741,059
Current assets:Total assets13,96712,727
Current liabilities:Accounts payable608570
Current liabilities:Employee compensation and benefits423443
Current liabilities:Deferred revenue640624
Current liabilities:Short-term debt304304
Current liabilities:Other accrued liabilities314406
Current liabilities:Total current liabilities2,2892,347
Current liabilities:Long-term debt3,6453,050
Current liabilities:Retirement and post-retirement benefits128126
Current liabilities:Other long-term liabilities542463
Current liabilities:Total liabilities6,6045,986
Stockholders' equity:Common stock; $0.01 par value; 2,000,000,000 shares authorized; 281,965,813 shares at July 31, 2026 and 283,054,377 shares at October 31, 2025, issued and outstanding33
Stockholders' equity:Additional paid-in-capital5,6815,575
Stockholders' equity:Retained earnings1,9121,389
Stockholders' equity:Accumulated other comprehensive loss-233-226
Stockholders' equity:Total stockholders' equity7,3636,741
Stockholders' equity:Total liabilities and stockholders' equity13,96712,727

Cash Flow

Nine Months Ended — PRELIMINARY

Nine Months Ended – July 31, – 2026Nine Months Ended – July 31, – 2025
Cash flows from operating activities:Net income1,006869
Adjustments to reconcile net income to net cash provided by operating activities:Depreciation and amortization200217
Adjustments to reconcile net income to net cash provided by operating activities:Share-based compensation105102
Adjustments to reconcile net income to net cash provided by operating activities:Deferred taxes expense (benefit)77-35
Adjustments to reconcile net income to net cash provided by operating activities:Excess and obsolete inventory related charges3530
Adjustments to reconcile net income to net cash provided by operating activities:Net (gain) loss on equity securities228
Adjustments to reconcile net income to net cash provided by operating activities:Asset impairment charges15
Adjustments to reconcile net income to net cash provided by operating activities:Other non-cash (income) expense, net124
Changes in assets and liabilities:Accounts receivable, net16-44
Changes in assets and liabilities:Inventory-110-72
Changes in assets and liabilities:Accounts payable41-13
Changes in assets and liabilities:Employee compensation and benefits-25-26
Changes in assets and liabilities:Other assets and liabilities-295-61
Changes in assets and liabilities:Net cash provided by operating activities (a)1,0641,014
Cash flows from investing activities:Payments to acquire property, plant and equipment-249-314
Cash flows from investing activities:Proceeds from sale of equity securities5
Cash flows from investing activities:Proceeds from convertible note2
Full release

(4) guidance on continued operational momentum

Third-quarter fiscal year 2026

• Revenue of $1.88 billion for the third quarter ended July 31, 2026, representing growth of 8.1% reported and up 7.3% core

(1) compared with the third quarter of fiscal year 2025.

• GAAP operating margin of 23.6%, expanded by 290 basis points year-over-year and 190 basis points sequentially.

• Non-GAAP operating margin

(2) of 28.3% (including an approximately 110 basis point net benefit from tariff refunds), expanded by 320 basis points year-over-year and 190 basis points sequentially.

• GAAP net income of $362 million; earnings per share (EPS) of $1.28, an increase of 8% from the third quarter of fiscal year 2025.

• Non-GAAP net income

(3) of $459 million (including a $17 million net benefit from tariff refunds); non-GAAP EPS

(3) of $1.62 (including a $0.06 net benefit from tariff refunds), an increase of 18% from the third quarter of fiscal year 2025.

Fiscal year 2026 improved outlook and fourth-quarter guidance

• Fiscal year 2026 revenue is now expected in the range of $7.49 billion to $7.51 billion, representing a range of up 7.8% to 8.1% reported and up 5.8% to 6.0% core,

(1)(5) an increase of 65 basis points at the midpoint.

• Non-GAAP fiscal year 2026 operating margin expansion

(2) at the midpoint of core revenue growth guidance is now expected to be over 130 basis points (including approximately 30 basis points in net benefit from tariff refunds in the third quarter).

• Non-GAAP fiscal year 2026 EPS

(4) is now expected in the range of $6.18 to $6.21, an increase of 15 cents at the midpoint (including $0.06 net benefit from tariff refunds in the third quarter) versus our prior guide.¹

• Fourth-quarter 2026 revenue is expected in the range of $1.98 billion to $2.0 billion, growth of 6.4% to 7.4% reported and up 5.2% to 6.2% core

(1)(5). Non-GAAP EPS

(4) is expected in the range of $1.71 to $1.74 per share. This guidance does not include any future benefit from tariff refunds.

SANTA CLARA, California, August 26, 2026 — Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.88 billion for the third quarter ended July 31, 2026, representing growth of 8.1% reported and up 7.3% core

(1) compared with the third quarter of fiscal year 2025.

Third-quarter GAAP net income was $362 million, or $1.28 per share. This compares with $336 million, or $1.18 per share, in the third quarter of fiscal year 2025. Non-GAAP net income

(3) was $459 million (including a $17 million net benefit from tariff refunds), or $1.62 per share (including a $0.06 net benefit from tariff refunds), during the quarter, compared with $390 million, or $1.37 per share, during the year-ago quarter.

“Agilent’s exceptional third-quarter performance reflects the sustained momentum created by our strategy, our execution discipline, and the compounding impact of the Ignite Operating System,” said Agilent CEO Padraig McDonnell. “We are seeing improving end markets, stronger demand in key regions, and excellent customer response to our innovative product launches. All of this gives us confidence in our increased outlook and our ability to sustainably outperform our end markets.”

Financial Highlights

Life Sciences and Diagnostics Markets Group

The Life Sciences and Diagnostics Markets Group (LDG) reported third-quarter revenue of $746 million, growth of 11% reported and 10% core

(1) year-over-year. LDG’s operating margin for the quarter was 23.5%.

Agilent CrossLab Group

The Agilent CrossLab Group (ACG) reported third-quarter revenue of $786 million, growth of 6% reported and 5% core

(1) year-over-year. ACG’s operating margin for the quarter was 34.3%.

Applied Markets Group²

The Applied Markets Group (AMG) reported third-quarter revenue of $346 million, growth of 7% reported and 7% core

(1) year-over-year. AMG’s operating margin for the quarter was 24.9%.

Conference Call

Agilent’s management will present additional details regarding the company’s third-quarter 2026 financial results on a conference call with investors today at 1:30 p.m. PT. This event will be broadcast live online in listen-only mode. To listen to the webcast, select the “Q3 2026 Agilent Technologies, Inc. Earnings Conference Call” link on the Agilent Investor Relations website. The replay of the call will remain on the company website for 90 days.

About Agilent Technologies

Agilent Technologies, Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

Forward-Looking Statements... (truncated)n the strength of Agilent’s customers’ businesses; unforeseen changes in the demand for current and new products, technologies, and services; unforeseen changes in the currency markets; customer purchasing decisions and timing; and the risk that Agilent is not able to realize the savings expected from integration and restructuring activities. In addition, other risks that Agilent faces in running its operations include the ability to execute successfully through business cycles; the ability to meet and achieve the benefits of its operational transformation, customer and market-focused strategy and cost-reduction goals and otherwise successfully adapt its cost structures to continuing changes in business conditions; ongoing competitive, pricing and gross-margin pressures; the risk that its cost-cutting initiatives will impair its ability to develop products and remain competitive and to operate effectively; the impact of geopolitical uncertainties and global economic conditions on its operations, its markets and its ability to conduct business; the ability to improve asset performance to adapt to changes in demand; the impact relating to or arising from changes³ to tariffs, import/export or trade policies; the ability of its supply chain to adapt to changes in demand; the ability to successfully introduce new products at the right time, price and mix; the ability of Agilent to successfully integrate recent acquisitions; the ability of Agilent to successfully comply with certain complex regulations; and other risks detailed in Agilent’s filings with the Securities and Exchange Commission, including its quarterly report on Form 10-Q for the fiscal quarter ended April 30, 2026. Forward-looking statements are based on the beliefs and assumptions of Agilent’s management and on currently available information. Agilent undertakes no responsibility to publicly update or revise any forward-looking statement.

(1) Core or organic constant currency revenue growth excludes the impact of currency and acquisitions and divestitures within the past 12 months. Core or organic constant currency revenue is a non-GAAP measure. Reconciliations between GAAP revenue and core or organic constant currency revenue for third quarter 2026 are set forth on page 7 of the attached tables along with additional information regarding the use of this non-GAAP measure. Core or organic constant currency revenue growth rate as projected for fourth quarter 2026 and full fiscal year 2026 excludes the impact of currency and acquisitions and divestitures within the past 12 months. Most of the excluded amounts pertain to events that have not yet occurred and are not currently possible to estimate with a reasonable degree of accuracy and could differ materially. Therefore, no reconciliation to GAAP amounts has been provided for the projection.

(2) Non-GAAP operating margin excludes the impacts of restructuring and other related costs, intangibles amortization, transformation initiatives and acquisition and integration costs. A reconciliation between non-GAAP operating margin and GAAP operating margin is set forth on page 5 of the attached tables along with additional information regarding the use of this non-GAAP measure. Non-GAAP operating margin as projected for full fiscal year 2026 excludes primarily the impacts of restructuring and other related costs, intangible amortization, transformation initiatives and acquisition and integration costs. Most of these excluded amounts pertain to events that have not yet occurred and are not currently possible to estimate with a reasonable degree of accuracy and could differ materially. Therefore, no reconciliation to GAAP amounts has been provided.

(3) Non-GAAP net income and non-GAAP EPS exclude the impacts of restructuring and other related costs, intangibles amortization, transformational initiatives, acquisition and integration costs and net (gain) loss on equity securities. Agilent also excludes any tax benefits or expenses that are not directly related to ongoing operations, and which are either isolated or are not expected to occur again with any regularity or predictability. A reconciliation between non-GAAP net income and GAAP net income and a reconciliation between non-GAAP EPS and GAAP EPS is set forth on page 4 of the attached tables along with additional information regarding the use of this non-GAAP measure.

(4) Non-GAAP EPS as projected for fourth quarter 2026 and full fiscal year 2026 exclude primarily the estimated impacts of non-cash intangibles amortization, transformational initiatives, and acquisition and integration costs. Agilent also excludes any tax benefits or expenses that are not directly related to ongoing operations, and which are either isolated or are not expected to occur again with any regularity or predictability. Most of these excluded amounts pertain to events that have not yet occurred and are not currently possible to estimate with a reasonable degree of accuracy and could differ materially. Therefore, no reconciliation to GAAP amounts has been provided. Future amortization of intangibles is expected to be approximately $27 million per quarter.

(5) Core or organic constant currency revenue growth outlook is based on forecasted currency exchange rates.⁴

# # #

INVESTOR CONTACT:

Tejas Savant

+1 917-574-4018 tejas.savant@agilent.com

Media Contact:

Andréa Topper

408-709-0060 andrea.topper@agilent.com⁵

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Agilent Technologies earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.